BLS International Services Limited (BOM:540073)

Marinus Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	24,112	21,933	16,768	15,162	8,499	4,784
Other Revenue	-	-	-	-	-	53.14
Revenue	24,112	21,933	16,768	15,162	8,499	4,837
Revenue Growth (YoY)	35.01%	30.80%	10.59%	78.40%	75.71%	-39.00%
Cost of Revenue	14,230	13,095	11,762	11,705	6,516	3,812
Gross Profit	9,882	8,838	5,006	3,456	1,983	1,025
Selling, General & Admin	-	-	289.99	204.14	192.18	126.32
Other Operating Expenses	2,878	2,545	1,236	969.27	607.94	446.43
Operating Expenses	3,730	3,310	1,835	1,358	970.73	668.73
Operating Income	6,152	5,528	3,171	2,098	1,013	356.52
Interest Expense	-322.67	-277.78	-25.32	-5.61	-4.41	-2.21
Interest & Investment Income	-	-	371.14	116.45	54.14	49.94
Currency Exchange Gain (Loss)	-	-	-23.89	-71.01	-9.97	29.33
Other Non Operating Income (Expenses)	880.56	805.05	23.2	89.26	93.1	-3.22
EBT Excluding Unusual Items	6,710	6,055	3,516	2,227	1,145	430.36
Gain (Loss) on Sale of Investments	-	-	4.43	3.92	-	-
Gain (Loss) on Sale of Assets	-	-	0.02	1.44	-1.33	0.74
Asset Writedown	-	-	-	-1.63	-4.59	-
Other Unusual Items	-	-	-	-26	-	52.56
Pretax Income	6,710	6,055	3,521	2,205	1,140	483.65
Income Tax Expense	711.67	658.76	264.52	162.23	27.56	-19.67
Earnings From Continuing Operations	5,998	5,396	3,256	2,043	1,112	503.32
Minority Interest in Earnings	-347.97	-314.21	-126.53	-35.07	0.7	-1.78
Net Income	5,650	5,082	3,130	2,008	1,113	501.54
Net Income to Common	5,650	5,082	3,130	2,008	1,113	501.54
Net Income Growth	57.73%	62.39%	55.89%	80.42%	121.86%	-4.33%
Shares Outstanding (Basic)	412	412	411	411	410	410
Shares Outstanding (Diluted)	412	412	411	411	410	410
Shares Change (YoY)	-0.04%	0.19%	0.20%	0.07%	0.12%	-
EPS (Basic)	13.72	12.34	7.61	4.89	2.71	1.22
EPS (Diluted)	13.71	12.33	7.60	4.89	2.71	1.22
EPS Growth	57.79%	62.24%	55.44%	80.42%	121.43%	-4.33%
Free Cash Flow	-	6,676	2,860	1,924	1,183	401.95
Free Cash Flow Per Share	-	16.20	6.95	4.69	2.88	0.98
Dividend Per Share	-	1.000	1.000	0.750	0.375	0.125
Dividend Growth	-	-	33.33%	100.00%	200.00%	-50.00%
Gross Margin	40.98%	40.29%	29.86%	22.80%	23.34%	21.20%
Operating Margin	25.52%	25.20%	18.91%	13.84%	11.92%	7.37%
Profit Margin	23.43%	23.17%	18.66%	13.24%	13.09%	10.37%
Free Cash Flow Margin	-	30.44%	17.06%	12.69%	13.93%	8.31%
EBITDA	7,047	6,293	3,418	2,247	1,071	446.98
EBITDA Margin	29.23%	28.69%	20.39%	14.82%	12.60%	9.24%
D&A For EBITDA	894.92	765.4	247.33	149.28	58.02	90.46
EBIT	6,152	5,528	3,171	2,098	1,013	356.52
EBIT Margin	25.52%	25.20%	18.91%	13.84%	11.92%	7.37%
Effective Tax Rate	10.61%	10.88%	7.51%	7.36%	2.42%	-
Revenue as Reported	24,993	22,738	17,168	15,374	8,648	4,970
Advertising Expenses	-	-	39.01	35.08	55.71	12.85

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.